My lab develops and tests acceptance-based therapies delivered in digital and telehealth platforms, with a focus on addressing health disparities. The most preventable causes of premature death and human suffering are cigarette smoking and obesity. To this end, my research team focuses on designing, developing, and testing AI-based chatbot, smartphone app-delivered, and telephone coach-delivered contextual behavioral interventions for smoking cessation and for weight loss. Research aims include main outcome comparisons, mediators, moderators, intervention engagement, and therapeutic process predictors of outcome. This research is currently supported by multiple NIH R01-level grants. Our lab’s latest grant focuses on testing a smartphone app for helping American Indians and Alaska Natives stop smoking commercial cigarettes.
See links for further information:
https://research.fredhutch.org/habit/en/habit-group-members.html
https://en.wikipedia.org/wiki/Jonathan_Bricker
Dr. Dahyeon Kang is an Assistant Professor at the University of Washington School of Medicine. She earned her doctoral degree from the University of Illinois at Urbana-Champaign, where her work focused on the etiology of alcohol and substance use disorders through multimodal research methods, including alcohol administration, neuroimaging, transdermal biosensors, and ecological momentary assessments. At the University of Washington’s Department of Psychiatry, Dr. Kang investigates how individual and social factors interact to influence alcohol and cannabis use behaviors.
Hello! I’m the medical director for the Long Term Civil Commitment Units at the Center for Behavioral Health and Learning. This is a new program as of July 2024 and I am excited to help get it off the ground. I completed my medical school training at the University of Cincinnati, then residency at Oregon Health & Science University, then addiction psychiatry fellowship at UW, then worked at the Puget Sound VA for five years and Providence Swedish for six years prior to starting at UW. I’m thrilled to be part of the team here and looking forward to this next chapter in my career.
I am a trained Behavioral Psychologist with a PhD in Health & Human Performance. The main goal of my work is to reduce substance-related harms and improve quality of life for people experiencing problems related to their substance use. I work closely with community members who use drugs to inform my line of research and address key needs identified. My primary appointment is at the Harm Reduction Research and Treatment (HaRRT) Center within the UW School of Medicine and hold an Affiliate Faculty appointment within the School of Public Health. My aim is to adapt, refine, and disseminate harm reduction programs through digital health interventions to empower individuals and ameliorate substance-related harms.
Dr. Walukevich-Dienst (hear my name) is a licensed clinical psychologist and an Assistant Professor at the University of Washington.
Her research is focused on identifying psychosocial and contextual factors associated with alcohol and cannabis misuse and co-use among young adults, including social influences (e.g., romantic partners, use partnerships), affect management motives, co-occurring mental health concerns, and high-risk substance use events and contexts.
Dr. Walukevich-Dienst aims to leverage this information to develop and test innovative, technology-informed prevention and intervention efforts to disseminate in real world settings.
She also provides psychotherapy to patients at the University of Washington’s Outpatient Psychiatry Clinic and provides supervision and training to psychology graduate students and psychiatry residents in Cognitive Behavioral Therapy.
Link to Dr. Walukevich-Dienst’s CV.
Koriann Cox, Ph.D. graduated from Northeastern University and is licensed in the state of Washington. She completed a postdoctoral fellowship in co-occurring addiction and mental health and has a range of clinical experience with a variety of concerns including depression, anxiety, trauma, reproductive mental health, and substance and behavioral addictions. Dr. Cox’s strengths-focused approach emphasizes the mutual development of goals for therapy and ongoing collaboration between herself, the patient, and the care team. Dr. Cox uses a number of therapeutic modalities including but not limited to Cognitive Behavioral Therapy, Acceptance and Commitment Therapy, and Cognitive Processing Therapy.
Dr. Hatch is an Associate Professor at the Addictions, Drug & Alcohol Institute (ADAI), Department of Psychiatry & Behavioral Sciences, UW School of Medicine. Her research interests are in the development and testing of behavioral and pharmacologic interventions for substance use disorders and HIV prevention. In particular, her work has focused on the intersection of substance use and HIV-related sex and drug risk behaviors from both the consumer and workforce perspectives, and on implementation factors that affect uptake of interventions. She has held multiple and varied roles in research projects since 1994, and has long-standing experience developing, implementing, and overseeing large-scale multi-site clinical trials with community treatment providers. In addition to her work at the University of Washington, Dr. Hatch is a licensed clinical psychologist at UWMC Outpatient Psychiatry Clinic. Her clinical work specializes in the treatment of drug and alcohol addictions and co-occurring depression, anxiety and trauma.
